Most people who get a flu shot or a COVID vaccine experience mild, short-lived side effects that peak within the first day or two and resolve on their own. The most common reactions are soreness at the injection site, fatigue, headache, and muscle aches. These symptoms are not a sign that something has gone wrong. They reflect your immune system responding to the vaccine, and the intensity varies widely from person to person based on factors like age, sex, prior infections, and even which vaccine platform you received.
Common Side Effects and Their Timeline
Side effects from both flu and COVID vaccines fall into two broad categories: local reactions at the injection site and systemic reactions that affect your whole body. Local reactions include pain, redness, swelling, and sometimes a firm spot under the skin. Systemic reactions include fatigue, headache, muscle aches, chills, and fever.1PubMed Central. The how’s and what’s of vaccine reactogenicity Injection-site soreness tends to start within hours and is usually worst the day after vaccination. Systemic symptoms follow a similar pattern, often starting six to twelve hours after the shot and peaking around 24 hours.
For COVID mRNA vaccines specifically, side effects after the second dose have historically been more noticeable than after the first. This pattern makes biological sense: your immune system has already been primed by the first dose, so it mounts a faster and stronger inflammatory response the second time around. For flu shots, since most adults have encountered influenza antigens many times before, each annual dose functions more like a booster, and side effects tend to be consistent year to year.
Most common reactions clear up within one to three days. If you still feel off after 72 hours, or if redness and swelling at the injection site keep expanding, it is worth contacting your doctor, not because something dangerous is necessarily happening, but because other explanations (like a skin infection) should be considered.
Why Side Effects Happen in the First Place
Your body does not distinguish between a real threat and a vaccine-delivered antigen with surgical precision. When the vaccine enters your tissue, your innate immune system launches an inflammatory response. Immune cells rush to the injection site, release signaling molecules called cytokines, and begin processing the foreign material. That wave of inflammation is what causes the soreness, swelling, and warmth you feel in your arm, and when the cytokines spill into your bloodstream, they trigger systemic symptoms like fever, fatigue, and aches.
Research on mRNA COVID vaccines has identified specific cytokines that drive these reactions. IL-6 appears to be a particularly strong contributor to fever and general malaise after vaccination, while TNF-α plays a larger role after booster doses, when T cells from the first dose amplify the inflammatory cascade.2Molecular Therapy. Mechanisms of systemic and local adverse reactions after mRNA vaccination Interestingly, IL-6 appears to contribute heavily to side effects while having relatively little impact on the vaccine’s ability to generate protective antibodies, which has researchers exploring whether future vaccines could be engineered to produce less of it.
The delivery vehicle matters, too. mRNA vaccines use lipid nanoparticles to carry the genetic instructions into your cells. These tiny fat capsules are not inert packaging. They activate parts of the innate immune system on their own, functioning somewhat like a built-in adjuvant.3PubMed. Dissecting lipid nanoparticle adjuvanticity and reactogenicity to optimize vaccine formulations Animal studies have shown that lipid nanoparticles can trigger toll-like receptors, a family of immune sensors that set off inflammation when they detect something foreign.4PubMed Central. Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis This partly explains why mRNA vaccines tend to produce more noticeable short-term reactions than some other vaccine types.
People whose innate immune systems respond more vigorously to the vaccine tend to experience more side effects. One study found that participants with a strong early innate immune response had roughly six times the odds of developing at least one moderate symptom compared to those with a weaker response.5Vaccine: X. Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity This does not mean stronger side effects guarantee better protection, but there is clearly a link between how hard your immune system fires up initially and how rough you feel afterward.
How Vaccine Type Affects What You Feel
Not all flu and COVID vaccines are created equal when it comes to side effects. The vaccine platform, meaning the underlying technology used to deliver the antigen, has a measurable influence on the frequency and intensity of reactions.
Among COVID vaccines, protein-based options like Novavax’s vaccine have consistently shown lower rates of side effects compared to mRNA vaccines from Pfizer and Moderna. A study of healthcare workers found that Novavax recipients reported an average of 1.7 systemic symptoms versus 2.8 for Pfizer recipients. About 24% of Novavax recipients experienced a symptom rated moderate or higher, compared to about 44% of Pfizer recipients. The impact on daily activities was also lower: Novavax recipients lost less productive time and missed fewer work hours on average.6Novavax. SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA The biological explanation lines up with the mechanism discussed above: protein-based vaccines do not use lipid nanoparticles, and they do not cause your own cells to produce the antigen. A mouse study comparing the two platforms found significantly lower levels of inflammatory signaling molecules after the protein vaccine than after the mRNA vaccine.7PubMed Central. Cytokine and Chemokine Production in Mice Inoculated with NVX-CoV2373 (Nuvaxovid®) in Comparison with Omicron BA.4/5 Bivalent BNT162b2 (Comirnaty®)
For flu vaccines, a similar dynamic exists between standard-dose and high-dose formulations. High-dose flu shots, designed for adults 65 and older, contain four times the antigen of the standard shot. In a large comparison, about 37% of high-dose recipients reported at least one local or systemic side effect, versus 22% of standard-dose recipients. However, the vast majority of these reactions were mild or moderate, and severe side effects were rare in both groups, with no real difference in the number of people who needed medical attention.8PubMed Central. Comparison of Side Effects of the 2015–2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥65 Years In the longer term, serious adverse events after high-dose and standard-dose flu vaccines occurred at similar rates.9PubMed. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season
Getting Both Shots at the Same Time
Fall vaccination campaigns often encourage people to get their flu shot and COVID booster in a single visit. A reasonable question is whether rolling both into one appointment doubles the misery. The short answer: the side-effect increase is real but small.
A large U.S. study found that people who received a flu vaccine and a COVID mRNA booster at the same visit were slightly more likely to report a systemic reaction in the following week than those who received the COVID booster alone. The increase was modest for both Pfizer and Moderna boosters.10JAMA Network Open. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US A separate randomized trial of a recombinant COVID vaccine given alongside an inactivated flu vaccine found no significant difference in adverse events between simultaneous and separate administration, and no evidence that giving both at once weakened the immune response to either one.11PubMed Central. Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults
The practical takeaway is that co-administration is safe and convenient. You might feel slightly worse for a day compared to getting one shot alone, but you avoid the hassle of scheduling two visits during a busy season, and you are protected against both viruses sooner.
Who Tends to React More
Your side-effect experience is not random. Several personal factors consistently predict whether you will breeze through vaccination or spend the next day on the couch.
Sex is one of the strongest predictors. Women consistently report more frequent and more severe vaccine side effects than men. In one retrospective study of COVID vaccine recipients, about 77% of women reported adverse effects compared to 65% of men, with women reporting higher rates of severe injection-site pain, skin reactions, nausea, and cardiopulmonary symptoms.12PubMed Central. COVID-19 vaccination, do women suffer from more side effects than men? A retrospective cross-sectional study This pattern holds across many types of vaccines and is thought to relate in part to hormonal differences that influence immune function. Estrogen tends to amplify immune responses, while testosterone has a dampening effect.
Age plays a role too, though the relationship is not perfectly linear. Younger adults generally mount more robust immune responses and tend to experience more systemic side effects from COVID vaccines. With flu vaccines, one study in Ethiopia found that reported reactions actually peaked in the 50-to-60 age group and were lower in both younger and older adults.13PubMed Central. COVID-19 vaccine side effect: age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia The takeaway is that age influences side effects, but the direction and magnitude depend on the vaccine and the population studied.
Prior infection with the virus the vaccine targets also matters. People who had COVID before getting vaccinated tend to react more strongly than those who were infection-naive, especially after the first dose.14PubMed Central. Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection Their immune system already has memory cells primed to respond, so the vaccine triggers a stronger recall reaction. In a nationwide cohort study, previously infected patients had a measurable spike in hospitalization rates the day after their second dose, returning to baseline shortly after. Chart reviews showed the hospitalizations were driven by vaccine side effects like fever, weakness, and falls rather than by the vaccine causing a new illness.15PubMed Central. Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination
The Nocebo Effect Is Larger Than You Would Guess
A surprisingly large share of vaccine side effects may be partly psychological. In a meta-analysis of COVID-19 vaccine trials, about 35% of people who received a placebo (an injection with no active vaccine ingredient) reported systemic side effects like headache and fatigue after the first dose. After the second dose, about 32% of placebo recipients reported them. The researchers estimated that nocebo responses, meaning side effects driven by expectation rather than pharmacology, accounted for roughly 76% of systemic adverse events after the first vaccine dose and about 52% after the second.16JAMA Network Open. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis
This does not mean those people were making it up. The nocebo effect produces real physical symptoms through real neurological pathways. If you expect to feel bad after a shot, your brain can deliver on that expectation. One prospective study found that people with higher levels of vaccine hesitancy before getting their COVID shot reported more severe side effects afterward, independent of other factors. The effect was significant for both men and women, though it was particularly strong in men.17Scientific Reports. Vaccine hesitancy prospectively predicts nocebo side-effects following COVID-19 vaccination
Understanding the nocebo component does not diminish anyone’s experience. But it does help explain why people who are anxious about vaccination often feel worse afterward, and why some individuals report dramatically different side effects from one dose to the next despite receiving the same product. If you go into your appointment expecting a rough day, that expectation alone can shape what your body delivers.
Delayed Skin Reactions and “COVID Arm”
Most vaccine reactions show up within a day or two, but one quirky exception has caught people off guard. “COVID arm” is a delayed skin reaction that appears roughly a week after an mRNA COVID vaccine injection. It shows up as a red, warm, sometimes itchy and firm patch near the injection site. It can be alarming because it appears well after you thought you were in the clear, and because it looks enough like a skin infection that it has been misdiagnosed as cellulitis.18PubMed Central. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis
The key differences from an actual infection: COVID arm tends to be itchy rather than deeply painful, it does not keep expanding aggressively, it responds well to topical steroids or antihistamines, and it typically resolves within about five days on its own. In a case series, the reaction appeared at a median of seven days after the first dose and lasted a median of five days.19JAMA Dermatology. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine Biopsies showed a pattern consistent with a mild allergic-type skin reaction rather than a bacterial infection. People who experienced COVID arm after their first dose could safely receive their second dose. If this happens to you, the main practical point is not to let it scare you into antibiotics you do not need.
Can You Take Pain Relievers After Vaccination
One of the most common questions after vaccination is whether it is okay to take ibuprofen or acetaminophen for the aches and fever. For years there was concern that anti-inflammatory medications might blunt the immune response you are trying to build. The evidence, however, is reassuring.
A review of existing studies found that observational data showed no negative effect of antipyretic or analgesic use on antibody responses to vaccines. A few small randomized trials did find slightly reduced antibody levels when these drugs were used, but only after primary vaccination with new antigens, and the effect disappeared after booster doses.20PubMed Central. Effect of antipyretic analgesics on immune responses to vaccination For COVID mRNA vaccines specifically, a study of over 2,000 people found that those who took NSAIDs or acetaminophen after vaccination actually had slightly higher antibody levels than those who did not, though the researchers attributed this to the fact that people who felt worse (and therefore had stronger immune activation) were also the ones reaching for the medicine. When participants were matched for symptom severity, there was no meaningful difference in antibody levels between those who took pain relievers and those who did not.21PubMed Central. No Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses
The bottom line for most adults: if you feel lousy after your flu or COVID shot, taking ibuprofen or acetaminophen is fine. The one scenario where guidelines have been slightly more cautious is prophylactic use, taking medication before the shot to preempt side effects. The concern there is theoretical and not well supported by data in adults receiving boosters, but if you want to be conservative, wait until symptoms actually appear before reaching for the pill bottle.
Rare but Serious Reactions
The overwhelming majority of vaccine side effects are mild and temporary. But rare serious reactions do occur, and knowing what they look like and how uncommon they are helps put risk in perspective.
Myocarditis, or inflammation of the heart muscle, became the most discussed rare side effect of mRNA COVID vaccines. It occurs primarily in young males and most often after the second dose. According to CDC data, the rate was roughly 12.6 cases per million second doses among people aged 12 to 39.22PubMed Central. Myocarditis With COVID-19 mRNA Vaccines In males aged 12 to 17, the risk was higher: about 66 cases per million second doses of the Pfizer vaccine.23PubMed Central. Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations The risk also differed between vaccine brands. In young men aged 18 to 29, the Moderna vaccine carried roughly five times the risk of myocarditis compared to the Pfizer vaccine after the second dose, a finding from Canadian surveillance data.24PubMed Central. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines The likely reason is that the Moderna vaccine contained a larger dose of mRNA. Patients typically presented with chest pain two to three days after their second dose. Most cases were mild and resolved with supportive care.
For flu vaccines, the rare adverse event that gets the most attention is Guillain-Barré syndrome, a condition in which the immune system attacks peripheral nerves, causing weakness and sometimes paralysis. The link between flu vaccines and GBS has been debated for decades, and the data remain mixed. A 15-year population study in Denmark found a roughly doubled odds of GBS within one month of flu vaccination.25PubMed Central. Guillain–Barré syndrome following influenza vaccination: A 15‐year nationwide population‐based case–control study However, two other large studies, one using self-controlled case series methodology and another in Taiwanese older adults, found no significant increase in GBS risk after flu vaccination.26PubMed. Seasonal influenza vaccine and Guillain-Barré syndrome: A self-controlled case series study27JAMA Network Open. Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan Even in the study that did find an association, the absolute risk was tiny: 1.5% of GBS patients had received a flu vaccine in the prior month compared with 0.9% of controls. For context, the risk of GBS from an actual respiratory or gastrointestinal infection was roughly four times higher than any vaccine-associated risk, a point the self-controlled study made directly. So if there is an excess risk from flu vaccination at all, it is extremely small, measured in single-digit cases per million doses, and substantially lower than the neurological risk posed by the infections the vaccine prevents.
Severe allergic reactions (anaphylaxis) to either flu or COVID vaccines are possible but exceptionally rare, occurring on the order of a few cases per million doses. For mRNA COVID vaccines, some allergic reactions have been linked to polyethylene glycol (PEG), an ingredient in the lipid nanoparticle formulation. Skin testing in people evaluated either before or after a vaccine reaction found that about 13% tested positive for sensitivity to PEG or a related compound, though the clinical significance of a positive skin test is debated.28PubMed Central. Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines Anaphylaxis is the reason vaccination sites ask you to wait 15 minutes after your shot, so that trained staff can respond immediately if needed.
Vaccination During Pregnancy
Pregnant individuals understandably worry about whether vaccine side effects pose any unique risks. A systematic review of complications from COVID vaccines during pregnancy found that in most studies, there were no notable differences in outcomes between vaccinated and unvaccinated pregnant women.29PubMed Central. Complications of COVID-19 Vaccines during Pregnancy; a Systematic Review Two of the included studies did report higher rates of certain complaints in vaccinated women: one found that tingling or numbness was more common, and another noted more frequent uterine contractions when the second dose fell in the third trimester. But across the body of evidence, vaccination did not increase rates of miscarriage, preterm birth, or other serious pregnancy complications. The common side effects, soreness, fatigue, and low-grade fever, occurred at similar rates as in non-pregnant adults.
The fact that fever can theoretically pose risks during pregnancy, particularly in the first trimester, is worth noting. Health agencies generally recommend that pregnant people take acetaminophen if they develop a fever after vaccination, rather than simply toughing it out. This advice aligns with the reassuring data on pain-reliever use and antibody responses discussed earlier.
When to Worry Versus When to Wait It Out
The vast majority of side effects after flu and COVID vaccination are self-limiting nuisances. But some signals deserve prompt medical attention. Chest pain, shortness of breath, or a pounding heartbeat within a week of an mRNA COVID vaccine should be evaluated, especially in young men, because of the myocarditis signal. Difficulty breathing, swelling of the face or throat, hives, or rapid pulse within minutes to hours of any vaccination could indicate anaphylaxis and is a medical emergency. Sudden weakness in the limbs, difficulty walking, or facial drooping in the weeks following vaccination deserves urgent evaluation regardless of the specific vaccine received.
On the other hand, feeling tired, achy, and slightly feverish the day after your shot is normal. An arm so sore you don’t want to raise it is normal. A mild headache and some chills are normal. These are the kinds of side effects that a warm compress, some rest, and an over-the-counter pain reliever can handle. Planning to take it easy the day after vaccination, and scheduling your shot in your non-dominant arm, are small steps that can make the experience more manageable. If you have had strong reactions in the past and your concern is specifically about side effects rather than the vaccine’s core ingredients, it is also worth discussing alternative vaccine platforms with your provider, since protein-based options exist for COVID and several flu vaccine formulations differ in their reactogenicity profiles.